Impact of preoperative blood glucose levels on prognosis and postoperative complications in patients with pancreatic cancer

Wang,Shubin; Pan,Teng; Wang,Shuya; Zhang,Xiaokun; Peng,Li; Yang,Wuhan

doi:10.3892/ol.2025.14880

Impact of preoperative blood glucose levels on prognosis and postoperative complications in patients with pancreatic cancer

Authors:
- Shubin Wang
- Teng Pan
- Shuya Wang
- Xiaokun Zhang
- Li Peng
- Wuhan Yang
View Affiliations

Affiliations: Department of General Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China, Department of Oncology, Shijiazhuang First Hospital, Shijiazhuang, Hebei 050011, P.R. China, Department of General Medicine, Dalian Medical University, Dalian, Liaoning 116000, P.R. China, Department of Hepatobiliary Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China
Published online on: January 8, 2025 https://doi.org/10.3892/ol.2025.14880
Article Number: 135
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The relationship between diabetes and pancreatic cancer is well documented; however, the effect of preoperative blood glucose levels on prognosis and postoperative complications is currently unclear. The present study aimed to investigate the effect of preoperative blood glucose levels on overall survival (OS) and postoperative complications in patients with pancreatic cancer. This retrospective study included 225 patients with pancreatic cancer treated at The Fourth Hospital of Hebei Medical University from January 2015 to December 2020. Patients were grouped based on preoperative blood glucose levels (normal, ≤6.11 mmol/l; high, >6.11 mmol/l). Data on demographics, clinical history, tumor characteristics, treatment and laboratory results were collected. High preoperative blood glucose levels were associated with reduced OS time [hazard ratio (HR), 1.68; 95% confidence interval (CI), 1.15‑2.45; P=0.007] and increased postoperative complications (29.2 vs. 9.8%; χ²=13.658; P<0.001). Median OS time was significantly shorter in the high glucose group (14.2 vs. 20.5 months; HR, 1.96; 95% CI, 1.38‑2.77; P<0.001). Elevated CA19‑9 levels were also a predictor of poor OS (HR, 1.70; 95% CI, 1.06‑2.74; P=0.029). High preoperative blood glucose and elevated CA19‑9 levels were independent predictors of poor prognosis in patients with pancreatic cancer. This finding suggests that preoperative blood glucose levels have a greater impact on prognosis compared with a history of diabetes. Elevated preoperative blood glucose levels have poorer OS and a higher incidence of postoperative complications compared to those with lower preoperative glucose levels, underscoring the importance of preoperative glucose management. Effective preoperative blood glucose control may improve outcomes in patients with pancreatic cancer.

View Figures

View References

1	Siegel RL, Miller KD, Wagle NS and Jemal A: Cancer statistics, 2023. CA Cancer J Clin. 73:17–48. 2023. View Article : Google Scholar : PubMed/NCBI
2	Duan X, Wang W, Pan Q and Guo L: Type 2 diabetes mellitus intersects with pancreatic cancer diagnosis and development. Front Oncol. 11:7300382021. View Article : Google Scholar : PubMed/NCBI
3	Yamaguchi A, Tazuma S, Tamaru Y, Kusunoki R, Kuwai T, Kouno H, Toyota N, Sudo T, Kuraoka K and Kohno H: Long-standing diabetes mellitus increases concomitant pancreatic cancer risk in patients with intraductal papillary mucinous neoplasms. BMC Gastroenterol. 22:5292022. View Article : Google Scholar : PubMed/NCBI
4	Bures J, Kohoutova D, Skrha J, Bunganic B, Ngo O, Suchanek S, Skrha P and Zavoral M: Diabetes mellitus in pancreatic cancer: A distinct approach to older subjects with new-onset diabetes mellitus. Cancers (Basel). 15:36692023. View Article : Google Scholar : PubMed/NCBI
5	Wang X, Xu W, Hu X, Yang X and Zhang M: The prognostic role of glycemia in patients with pancreatic carcinoma: A systematic review and meta-analysis. Front Oncol. 12:7809092022. View Article : Google Scholar : PubMed/NCBI
6	Lv X, Qiao W, Leng Y, Wu L and Zhou Y: Impact of diabetes mellitus on clinical outcomes of pancreatic cancer after surgical resection: A systematic review and meta-analysis. PLoS One. 12:e01713702017. View Article : Google Scholar : PubMed/NCBI
7	Li Q, Feng Z, Miao R, Liu X, Liu C and Liu Z: Prognosis and survival analysis of patients with pancreatic cancer: Retrospective experience of a single institution. World J Surg Oncol. 20:112022. View Article : Google Scholar : PubMed/NCBI
8	Menini S, Iacobini C, de Latouliere L, Manni I, Vitale M, Pilozzi E, Pesce C, Cappello P, Novelli F, Piaggio G and Pugliese G: Diabetes promotes invasive pancreatic cancer by increasing systemic and tumour carbonyl stress in Kras^G12D/+ mice. J Exp Clin Cancer Res. 39:1522020. View Article : Google Scholar : PubMed/NCBI
9	Gong Y, Fan Z, Zhang P, Qian Y, Huang Q, Deng S, Luo G, Cheng H, Jin K, Ni Q, et al: High pre-operative fasting blood glucose levels predict a poor prognosis in patients with pancreatic neuroendocrine tumour. Endocrine. 71:494–501. 2021. View Article : Google Scholar : PubMed/NCBI
10	Raghavan SR, Ballehaninna UK and Chamberlain RS: The impact of perioperative blood glucose levels on pancreatic cancer prognosis and surgical outcomes: An evidence-based review. Pancreas. 42:1210–1217. 2013. View Article : Google Scholar : PubMed/NCBI
11	Andersen DK, Korc M, Petersen GM, Eibl G, Li D, Rickels MR, Chari ST and Abbruzzese JL: Diabetes, pancreatogenic diabetes, and pancreatic cancer. Diabetes. 66:1103–1110. 2017. View Article : Google Scholar : PubMed/NCBI
12	Pancreatic Cancer Committee of Chinese Anticancer Association, . Comprehensive guidelines for the diagnosis and treatment of pancreatic cancer (2020 version). Zhonghua Wai Ke Za Zhi. 59:81–100. 2021.(In Chinese). PubMed/NCBI
13	Gonzalez RS, Raza A, Propst R, Adeyi O, Bateman J, Sopha SC, Shaw J and Auerbach A: Recent advances in digestive tract tumors: Updates from the 5th edition of the World Health Organization ‘blue book’. Arch Pathol Lab Med. 145:607–626. 2021. View Article : Google Scholar : PubMed/NCBI
14	Yuan JX, Jiang Q and Yu SJ: Diabetes mellitus and prostate cancer risk: A mendelian randomization analysis. World J Diabetes. 14:1839–1848. 2023. View Article : Google Scholar : PubMed/NCBI
15	Wang Y, Cao Y and Zhu C: Meta-analysis of the relationship between type 2 diabetes mellitus and renal cancer risk. Endocr Metab Immune Disord Drug Targets. 24:832–839. 2024. View Article : Google Scholar : PubMed/NCBI
16	Boursi B, Finkelman B, Giantonio BJ, Haynes K, Rustgi AK, Rhim AD, Mamtani R and Yang YX: A clinical prediction model to assess risk for pancreatic cancer among patients with new-onset diabetes. Gastroenterology. 152:840–850.e3. 2017. View Article : Google Scholar : PubMed/NCBI
17	Pannala R, Leibson CL, Rabe KG, Timmons LJ, Ransom J, de Andrade M, Petersen GM and Chari ST: Temporal association of changes in fasting blood glucose and body mass index with diagnosis of pancreatic cancer. Am J Gastroenterol. 104:2318–2325. 2009. View Article : Google Scholar : PubMed/NCBI
18	Goodenough CJ, Liang MK, Nguyen MT, Nguyen DH, Holihan JL, Alawadi ZM, Roth JS, Wray CJ, Ko TC and Kao LS: Preoperative glycosylated hemoglobin and postoperative glucose together predict major complications after abdominal surgery. J Am Coll Surg. 221:854–861.e1. 2015. View Article : Google Scholar : PubMed/NCBI
19	Zhang X, Hou A, Cao J, Liu Y, Lou J, Li H, Ma Y, Song Y, Mi W and Liu J: Association of diabetes mellitus with postoperative complications and mortality after non-cardiac surgery: A meta-analysis and systematic review. Front Endocrinol (Lausanne). 13:8412562022. View Article : Google Scholar : PubMed/NCBI
20	Dougherty SM, Schommer J, Salinas JL, Zilles B, Belding-Schmitt M, Rogers WK, Shibli-Rahhal A and O'Neill BT: Immediate preoperative hyperglycemia correlates with complications in non-cardiac surgical cases. J Clin Anesth. 74:1103752021. View Article : Google Scholar : PubMed/NCBI
21	Gu J, Liu J, Hong Y, Feng Y and Huang X: Nomogram for predicting risk factor of urosepsis in patients with diabetes after percutaneous nephrolithotomy. BMC Anesthesiol. 22:872022. View Article : Google Scholar : PubMed/NCBI
22	Liu S, Xv L, Wu X, Wang F, Wang J, Tang X, Dong R, Wang B, Lin X and Bi Y: Potential value of preoperative fasting blood glucose levels in the identification of postoperative delirium in non-diabetic older patients undergoing total hip replacement: The perioperative neurocognitive disorder and biomarker lifestyle study. Front Psychiatry. 13:9410482022. View Article : Google Scholar : PubMed/NCBI
23	Balzano G, Dugnani E, Gandolfi A, Scavini M, Pasquale V, Aleotti F, Liberati D, Di Terlizzi G, Petrella G, Reni M, et al: Effect of diabetes on survival after resection of pancreatic adenocarcinoma. A prospective, observational study. PLoS One. 11:e01660082016. View Article : Google Scholar : PubMed/NCBI
24	Huxley R, Ansary-Moghaddam A, Berrington de González A, Barzi F and Woodward M: Type-II diabetes and pancreatic cancer: A meta-analysis of 36 studies. Br J Cancer. 92:2076–2083. 2005. View Article : Google Scholar : PubMed/NCBI
25	Perazzoli G, Garcia-Valdeavero OM, Peña M, Prados J, Melguizo C and Jiménez-Luna C: Evaluating metabolite-based biomarkers for early diagnosis of pancreatic cancer: A systematic review. Metabolites. 13:8722023. View Article : Google Scholar : PubMed/NCBI
26	Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Macdonald JS, Benson AB III and Fuchs CS: Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol. 21:433–440. 2003. View Article : Google Scholar : PubMed/NCBI
27	Abel ED, Gloyn AL, Evans-Molina C, Joseph JJ, Misra S, Pajvani UB, Simcox J, Susztak K and Drucker DJ: Diabetes mellitus-progress and opportunities in the evolving epidemic. Cell. 187:3789–3820. 2024. View Article : Google Scholar : PubMed/NCBI
28	Kleeff J, Korc M, Apte M, La Vecchia C, Johnson CD, Biankin AV, Neale RE, Tempero M, Tuveson DA, Hruban RH and Neoptolemos JP: Pancreatic cancer. Nat Rev Dis Primers. 2:160222016. View Article : Google Scholar : PubMed/NCBI
29	Duffy MJ, Sturgeon C, Lamerz R, Haglund C, Holubec VL, Klapdor R, Nicolini A, Topolcan O and Heinemann V: Tumor markers in pancreatic cancer: A European group on tumor markers (EGTM) status report. Ann Oncol. 21:441–447. 2010. View Article : Google Scholar : PubMed/NCBI
30	Ballehaninna UK and Chamberlain RS: Serum CA 19-9 as a biomarker for pancreatic cancer-A comprehensive review. Indian J Surg Oncol. 2:88–100. 2011. View Article : Google Scholar : PubMed/NCBI
31	Bhandare MS, Gupta V, Chaudhari V, Nandy K, Ostwal V, Ramaswamy A, Nashikkar C, Engineer R, Krishnatry R and Shrikhande SV: Differential impact of incrementally elevated CA 19-9 levels on prognosis of resected pancreatic ductal adenocarcinoma. HPB (Oxford). 26:1237–1247. 2024. View Article : Google Scholar : PubMed/NCBI
32	Guan S, Chen Y, Han Q, Deng G, Wang Y, Shi Y and Dai G: Preoperative CA19-9 levels predict disease-free survival and overall survival in pancreatic adenocarcinoma patients after resection. Transl Cancer Res. 8:811–820. 2019. View Article : Google Scholar : PubMed/NCBI
33	Cummings J, Ward TH, Greystoke A, Ranson M and Dive C: Biomarker method validation in anticancer drug development. Br J Pharmacol. 153:646–656. 2008. View Article : Google Scholar : PubMed/NCBI
34	Currie CJ, Poole CD and Gale EAM: The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia. 52:1766–1777. 2009. View Article : Google Scholar : PubMed/NCBI
35	Ghareghomi S, Arghavani P, Mahdavi M, Khatibi A, García-Jiménez C and Moosavi-Movahedi AA: Hyperglycemia-driven signaling bridges between diabetes and cancer. Biochem Pharmacol. 229:1164502024. View Article : Google Scholar : PubMed/NCBI
36	Lomelí Martínez SM, Cortés Trujillo I, Martínez Nieto M and Mercado González AE: Periodontal disease: A silent factor in the development and progression of diabetic retinopathy. World J Diabetes. 15:1672–1676. 2024. View Article : Google Scholar : PubMed/NCBI
37	Bowers LW, Rossi EL, O'Flanagan CH, deGraffenried LA and Hursting SD: The role of the insulin/IGF system in cancer: Lessons learned from clinical trials and the energy balance-cancer link. Front Endocrinol (Lausanne). 6:772015. View Article : Google Scholar : PubMed/NCBI
38	Kang JS, Choi YJ, Byun Y, Han Y, Kim JH, Lee JM, Sohn HJ, Kim H, Kwon W and Jang JY: Radiological tumour invasion of splenic artery or vein in patients with pancreatic body or tail adenocarcinoma and effect on recurrence and survival. Br J Surg. 109:105–113. 2021. View Article : Google Scholar : PubMed/NCBI
39	Dillon DL, Park JY, Mederos MA, Seo YJ, King J, Hines J, Donahue T and Girgis MD: Neoadjuvant chemotherapy is associated with improved disease-free survival in pancreatic cancer patients undergoing pancreaticoduodenectomy with vascular resection. J Surg Oncol. 130:72–82. 2024. View Article : Google Scholar : PubMed/NCBI